Suchit H. Patel et al. and Al‐Halabi H et al. found that the predominant failure in EGFR‐mutant (EGFR‐M)NSCLC without MPE is in the initial involved lesions (Rate, 79.6–82.4%).18, 19. This evidence concerns the gene EGFR and non-small cell lung carcinoma.